GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Manhattan Scientifics Inc (OTCPK:MHTX) » Definitions » EV-to-EBIT

Manhattan Scientifics (Manhattan Scientifics) EV-to-EBIT : -0.79 (As of Apr. 29, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Manhattan Scientifics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Manhattan Scientifics's Enterprise Value is $0.92 Mil. Manhattan Scientifics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.17 Mil. Therefore, Manhattan Scientifics's EV-to-EBIT for today is -0.79.

The historical rank and industry rank for Manhattan Scientifics's EV-to-EBIT or its related term are showing as below:

MHTX' s EV-to-EBIT Range Over the Past 10 Years
Min: -44.86   Med: -6.92   Max: -0.79
Current: -0.79

During the past 13 years, the highest EV-to-EBIT of Manhattan Scientifics was -0.79. The lowest was -44.86. And the median was -6.92.

MHTX's EV-to-EBIT is ranked worse than
100% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.9 vs MHTX: -0.79

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Manhattan Scientifics's Enterprise Value for the quarter that ended in Dec. 2023 was $1.45 Mil. Manhattan Scientifics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.17 Mil. Manhattan Scientifics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -80.50%.


Manhattan Scientifics EV-to-EBIT Historical Data

The historical data trend for Manhattan Scientifics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manhattan Scientifics EV-to-EBIT Chart

Manhattan Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.43 5.44 -2.45 -1.63 -1.24

Manhattan Scientifics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.63 -1.79 -2.79 -1.90 -1.24

Competitive Comparison of Manhattan Scientifics's EV-to-EBIT

For the Medical Devices subindustry, Manhattan Scientifics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Manhattan Scientifics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Manhattan Scientifics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Manhattan Scientifics's EV-to-EBIT falls into.



Manhattan Scientifics EV-to-EBIT Calculation

Manhattan Scientifics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.916/-1.165
=-0.79

Manhattan Scientifics's current Enterprise Value is $0.92 Mil.
Manhattan Scientifics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Manhattan Scientifics  (OTCPK:MHTX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Manhattan Scientifics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1.165/1.4471306
=-80.50 %

Manhattan Scientifics's Enterprise Value for the quarter that ended in Dec. 2023 was $1.45 Mil.
Manhattan Scientifics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Manhattan Scientifics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Manhattan Scientifics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Manhattan Scientifics (Manhattan Scientifics) Business Description

Traded in Other Exchanges
N/A
Address
244 Fifth Avenue, Suite 2341, New York, NY, USA, 10001
Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The company is focused on technology transfer and commercialization of transformative technologies.
Executives
Chris Theoharis director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Photios Frank Georgiou director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Emmanuel Tsoupanarias director, officer: Chief Executive Officer 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Leonard Friedman director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Marvin Maslow director, 10 percent owner, officer: Chief Executive Office MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
David Teich director, officer: Treasurer MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
Ralph Anderson director 641 FIFTH AVENUE SUITE 36F, NEW YORK NY 10022
Larry H Schatz director 152 W. 57TH STREET, 31ST FLOOR, NEW YORK NY 10019
Marty Steinberg 10 percent owner 1111 BRICKELL AVENUE SUITE 2500, MIAMI FL 33131
Scott Bach director, officer: Secretary MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022

Manhattan Scientifics (Manhattan Scientifics) Headlines

No Headlines